RYM compared with TTRX: revenue, margins and what each company keeps, and the suppliers and customers both name

RYMRythm, Inc.

Mkt capRevenueRevenue

TTRXTurn Therapeutics Inc.

Mkt capRevenueRevenue

Compare

RYMRythm, Inc.

TTRXTurn Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RYM2 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▲+6.73%—

Q2 FY26—▲+23.20%—

TTRX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.45%—

= impliedRYM realized, solidTTRX realized, hatchedOne scale, both sides: full bar = 24%× = |realized| ÷ impliedSource: market data

RYMRythm, Inc.

16.42▲+1.05%· post 16.42

Mkt cap$122.3MRevenue$24MQ3 FY26Revenue$17MFY25

TTRXTurn Therapeutics Inc.

9.13▲+2.15%· post 9.14

ClosedNov 6 '26

Mkt cap$282.4MRevenue—Revenue—

Compare

ClosedNov 6 '26

RYMRythm, Inc.

TTRXTurn Therapeutics Inc.

16.42▲+1.05%post 16.42

Price

9.13▲+2.15%post 9.14

$122.3M

Mkt cap

$282.4M

Q3 FY26$24M

Revenue

—

FY25$17M

Revenue

—

RYM16.42▲+1.05%vsTTRX9.13▲+2.15%ClosedNov 6 '26